Reprod 57 , 14131419 (1997)
suggest that this peptide also interacts with ghrelin receptors located within the nervous system, potentially promoting signals associated with an observable elevation in hunger hormone signaling
A rare but serious side effect of DPP-4 inhibitors is: a
This activity is designated for 1.25 AAPA Category 1 CME credits
In addition, there is some evidence that patients started on GLP-1 RAs may actually decrease their physical activity 39
Contact your GP, diabetes specialist nurse, or NHS 111 if: Headaches are persistent, worsening, or significantly impacting daily activities despite simple management measures You experience frequent hypoglycaemic episodes (blood glucose below 4 mmol/L) [31] [32] You have signs of dehydration such as reduced urine output, excessive thirst, or dizziness when standing Side effects are affecting medication adherence or quality of life You develop new or unusual symptoms that concern you Headaches follow a different pattern from any pre-existing headache disorder Healthcare professionals can assess whether headaches are likely related to GLP-1 therapy or require investigation for alternative causes